IMIWN sTLR2 RAPID | New Opportunities in Sepsis Diagnostics

Developed and manufactured in the UK by J R Biomedical Limited, the IMIWN sTLR2 RAPID test is an in vitro diagnostic immunochromatographic (lateral-flow) assay for the detection of human soluble Toll-like receptor 2 (sTLR2) in plasma and whole blood - a biomarker of sepsis and other inflammatory conditions.

As a functional biomarker of innate immune system activation, the detection of sTLR2 in plasma can help provide earlier, and additional information to that of traditional biomarkers such as CRP and PCT, providing scientists and clinicians with a new, potentially transformative tool.

Certified for clinical use (UKCA) in Great Britain, and available for research use elsewhere.

Find out more about sTLR2 and sepsis diagnostics